{"disease":{"id":"virologic-failure","name":"virologic failure"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04612452","title":"The DTG-SWITCH Study: Longitudinal Analysis of Virologic Failure and Drug Resistance at and After Switching to Dolutegravir-based First-line ART","phase":"","overall_status":"COMPLETED","enrollment_count":2820,"lead_sponsor_name":"University of Bern","has_results":false},{"nct_id":"NCT05373758","title":"A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa","phase":"NA","overall_status":"RECRUITING","enrollment_count":648,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}